4//SEC Filing
ZUERBLIS KENNETH J 4
Accession 0001104659-19-038305
CIK 0001264587other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 5:15 PM ET
Size
4.7 KB
Accession
0001104659-19-038305
Insider Transaction Report
Form 4
ZUERBLIS KENNETH J
Director
Transactions
- Award
Common Stock
2019-06-25+15,000→ 60,121 total
Footnotes (2)
- [F1]The restricted shares will vest according to the following schedule: 5,000 shares on 6/25/2020, 5,000 shares on 6/21/2021 and 5,000 shares on 6/25/2022.
- [F2]Of the 60,121 shares, 27,105 shares are restricted stock.
Documents
Issuer
STEMLINE THERAPEUTICS INC
CIK 0001264587
Entity typeother
Related Parties
1- filerCIK 0001007923
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 5:15 PM ET
- Size
- 4.7 KB